The Erasmus MC - Cancer Computational Biology Center (CCBC) facilitates for researchers both bioinformatics and computational biology. The CCBC aims to innovate, facilitate and stimulate omics-based cancer research, including genomics, transcriptomics and proteomics, within the Erasmus Medical Center Cancer Institute. It maintains and develops a structured, dedicated and robust infrastructure for combining ongoing activities and creates synergy with different cancer research groups in the Departments of Pathology, Urology, Hematology, Medical Oncology, among others.
1. Understanding the origin and progression of cancer.
2. Identification of cancer biomarkers and therapy targets.
3. Implementation of Next Generation Sequencing (NGS)-based molecular diagnostics and personalized oncology. This is done in close collaboration with the Molecular Diagnostics group of Winand Dinjens.
4. Data integration, tool development, data storage and computational biology.
To achieve our research goals, the CCBC is collaborating heavily with the scientific groups of Guido Jenster, John Martens and Leendert Looijenga.
CCBC is establishing an (inter)national network of various research groups with experiences in computational biology.
Providing a state-of-the-art cancer-related bioinformatics platform at the Erasmus MC.
Analysis of clinical and molecular data to improve, on a personal level, clinical examination and treatment.
A good understanding of cancer and computational biology starts with a good education of BSc-,MSc- and PhD-students. Therefore, the CCBC is sharing its knowledge on cancer computational biology to students inside and outside the Erasmus MC.